NOTICE
The 10th U.S. – Japan Symposium on Drug Delivery Systems
Abstract Submissions Final Deadline is October 19, 2009

There will be no more extentions.
Submit Online

Reserve Hotel early to ensure group rate – reservation and deposit required by 11/21/09.
After 11/21/09 group rate is only available upon a space available basis only.
Register Now

10th US - Japan Symposium on Drug Delivery Systems

Agenda

Wednesday, December 16, 2009

2:30-5:30pm 
Registration -  Ocean Lanai Terrace

5:45–6:55pm
Welcome Reception

Evening Plenary Session

7:00-7:05pm   
Introduction: Robert Langer and Yasuhiko Tabata

Discussion Leader: Mike Sefton

7:05-7:45pm
John Santini
President and Chief Executive Officer, MicroCHIPS, Inc.
Addressing drug delivery challenges with intelligent implantable devices

7:45-8:25pm
Yasuyoshi Watanabe
Director, RIKEN Center for Molecular Imaging Science
Drug delivery systems and PK/PD studies with molecular imaging

8:25-8:55pm - Refreshment Break

88:55-9:35pm
Francis Szoka
Professor of Biopharmaceutical Sciences, University of California, San Francisco
Back to the future: New lipids to solve an old problem:  Drug and nucleic acid delivery

9:35-10:15pm
Joseph DeSimone
Chancellor’s Eminent Professor of Chemistry; Kenan Jr. Distinguished Professor of Chemical Engineering, University of North Carolina-Chapel Hill and North Carolina State University
On the role of size, shape, chemistry and deformability on drug delivery systems

Thursday, December 17, 2009

7:00 - 8:00am
Registration, Ocean Lanai Terrace

Morning Plenary Session

Discussion Leader: Allan Hoffman

8:30-9:10am
Kazunori Kataoka
Professor, University of Tokyo
Block copolymer micelles and vesicles as nanocarriers for gene and drug delivery

9:10-9:50am
Henry Brem
Director of Neurosurgery and Professor, Johns Hopkins School of Medicine
New approaches to treating brain tumors

9:50-10:30am
Shigeru Kawakami
Assistant Professor, Kyoto University
Development and evaluation of organ-press mediated in vivo gene transfection methods of plamid DNA and siRNA

10:30-11:00am – Refreshment Break

11:00-11:40am
Rodney Pearlman
President and Chief Executive Officer, Nuon Therapeutics, Inc.
Twenty years of protein drug delivery:  The good, the bad, the ugly

11:40am-12:20pm
Christine Bunt
Chief Operating Officer and Founder, TARIS Biomedical
Drug-device convergence for diseases of the bladder

Afternoon Unscheduled

Evening Plenary Session

7:00-7:40pm
Victor Kotelianski
Vice President of Research, Alnylam Pharmaceuticals
Achieving therapeutic silencing by RNAi

7:40-8:20pm
Juichi Ito
Professor and Chairman of the Department of Otolaryngology-Head and Neck Surgery, Kyoto University
New drug delivery systems for inner ear diseases

8:20-8:50pm - Refreshment Break

8:50-9:30pm
Sung Wan Kim
DDistinguished Professor of Pharmaceutics and Pharmaceutical Chemistry, University of Utah
Newly designed polymers for the delivery of siRNA

9:30-10:10pm
Lloyd Johnston
Vice President, Pharmaceutical Research and Development, Selecta Biosciences, Inc.
Title TBA

Friday, December 18, 2009

Morning Plenary Session

8:30-9:10am
Yoshinobu Baba
Professor, Nagoya University
Nanotechnology for cancer stem cell diagnosis and in vivo stem cell imaging for tissue engineering

9:10-9:50am
Gerald Bernstein
Vice President, Medical Affairs, Director, Generex Biotechnology Corp
Buccal delivery of insulin, etc: The evolving paradigm of natural history and treatment for diabetes and prediabetes

9:50-10:30am
Yasufumi Kaneda
Professor, Osaka University
Novel anti-cancer strategies using HVJ (Sendai virus) envelope

10:30-11:00am – Refreshment Break

11:00-11:40am
Nicholas Peppas
Fletcher Stuckey Pratt Chair in Engineering, University of Texas – Austin
Recognition and delivery:  The next generation of medical microdevices

11:40am-12:20pm
Kenji Hyodo
Scientist, Eisai Co., Ltd.
Inhibition of cancer metastasis by targeted delivery of antioxidant enzymes

Afternoon Unscheduled

Evening Session – Poster Session 1

7:30pm – 9:30pm
Oral Presentation of Posters - Selected from Poster Session #1 


8:30pm – Refreshment Break

SSession ends at approximately 10:00 pm

Saturday, December 19, 2009

Morning Plenary Session

8:30-9:10am
Koji Hanai
Scientist, Dainippon Sumitomo Pharma Co., Ltd.
Progress of atelocollagen-mediated drug delivery systems for nucleic acid medicines

9:10-9:50am
Jeff Hrkach
Vice President, Pharmaceutical Sciences, BIND Biosciences, Inc
The development of BIND targeted nanotherapeutics

9:50-10:30am
Eric Tomlinson
President and Chief Executive Officer, Altea Therapeutics Corp.
The efficient transdermal delivery of biotherapeutics from a conventional skin patch

10:30-11:00am - Refreshment Break

11:00-11:40am
Hideyuki Okano
Professor and Chairman, Department of Physiology, Keio University
EES/iPS cells based cell therapy for damaged CNS

11:40am-12:20pm
Oliver Fetzer
President and Chief Executive Officer, Cerulean Pharma, Inc.
Title TBA

Afternoon Unscheduled

Evening Plenary Session

7:30-8:10pm
John Patton
Founder and Chief Scientific Officer, Dance Pharma
Inhaled medicines for systemic action

8:10-8:50pm
Takayuki Yoshida
Scientist, Astellas Pharma, Inc.
pH-sensitive PEG release from nanoparticles for gene delivery

8:50-9:20pm - Refreshment Break

9:20-10:00pm
Shaoyi Jiang1 and Christopher Loose2
SAB Co-Chairman1; Chief Technology Officer2, Semprus BioSciences
Functional surfaces for medical devices

Sunday, December 20, 2009

Morning Plenary Session

88:30-9:10am
Howie Rosen
Independent Consultant
Ouch!  The role of drug delivery in pain management

9:10-9:50am
Yuichi Sugiyama
Professor, University of Tokyo
Evolutional drug development with the use of microdosing clinical trial:  Quantitative prediction of ADME with PET imaging

9:50-10:20am – Refreshment Break

10:20-11:00am
Maria Palasis
Executive Vice President, Research and Development, Arsenal Medical
Combination products in drug delivery:  Enabling site specific therapy with medical devices

11:00-11:40am
Ronald E. Peeples
AVP, Drug Product Development, Wyeth BioPharma
Title TBA

Afternoon Unscheduled

Evening Session – Poster Session 2        

7:30pm
Oral Presentation Of Posters - Selected From Poster Session #2       

8:30pm - Refreshment Break

Session Ends at Approximately 10:00 p.m.

Thank you for participating - we hope to see you again at the 11th Symposium in 2011.


 

 

*Drug delivery is a term that refers to the delivery of a pharmaceutical compound to humans or animals. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Many medications, however, can not be delivered using these routes because they might be susceptible to degradation or are not incorporated efficiently. For this reason many protein and peptide drugs have to be delivered by injection. For example, many immunizations are based on the delivery of protein drugs and are often done by injection.

Current efforts in the area of drug delivery include the development of targeted delivery in which the drug is only active in the target area of the body (for example, in cancerous tissues) and sustained release formulations in which the drug is released over a period of time in a controlled manner from a formulation.


*Source: Wikipedia
 

*Abstract
 Abstract (summary), an abbreviated summary of any in-depth analysis of a particular subject or discipline.

Abstraction (computer science), a high-level specification as opposed to a low-level implementation, which is "concrete".

Abstract object (philosophy), as opposed to "concrete".

Abstract art, a non-representational artwork, especially a painting.

Abstract (law), a brief statement of the most important points of one or more legal documents

 

*Source Wikipedia

 

Designed by V&V Design and Marketing